Viatris VTRS
NASDAQ VTRS
$16.50 -0.11 (-0.66%)
As of: Sep 9, 2026 · 3:59 PM EDT

Viatris (VTRS) Notes Payables (2020 - 2023)

Viatris (VTRS) posted Notes Payables of $100000.0 for Q3 2023, down 99.57% on a QoQ basis from $23.2 million in Q2 2023, and down 99.98% year-over-year from $500.4 million in Q3 2022.

Analysis

Viatris (VTRS) Notes Payables (2020 - 2023) Analysis & Trends

Viatris has reported Notes Payables for 4 years, with the latest figure at $100000.0 in Q3 2023.

  • On a quarterly basis, Notes Payables fell 99.98% year-over-year to $100000.0 in Q3 2023; TTM through Sep 2023 was $100000.0, a 99.98% decrease from a year earlier, with the FY2021 full-year figure at $1.5 billion, up 35.62% from the prior year.
  • Notes Payables was $100000.0 for Q3 2023 at Viatris, down from $23.2 million in the prior quarter.
  • The five-year high for Notes Payables was $1.7 billion in Q3 2021, with the low at $100000.0 in Q3 2023.
  • Average Notes Payables over 4 years is $731.4 million, with a median of $655.4 million recorded in 2022.
  • The sharpest annual moves came in 2022 and 2023: Notes Payables jumped 1676.15% in 2022, then sank 99.98% in 2023.
  • Over 4 years, Notes Payables stood at $1.1 billion in 2020, then soared by 35.62% to $1.5 billion in 2021, then sank by 66.48% to $500.4 million in 2022, then tumbled by 99.98% to $100000.0 in 2023.
  • The last three Notes Payables figures came in at $100000.0 (Q3 2023), $23.2 million (Q2 2023), and $204.6 million (Q1 2023), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 42.84 Bn 39.19 Bn 2.15 Bn
2 Viatris 19.13 Bn 18.24 Bn 1.46 Bn
3 Dr Reddys Laboratories 9.91 Bn 9.74 Bn 396.53 Mn
4 Amneal Pharmaceuticals 5.51 Bn 5.38 Bn 334.51 Mn
5 Bausch Health Companies 2.30 Bn 464.50 Mn 2.10 Bn
6 Alvotech 1.50 Bn 1.36 Bn 2.56 Mn
7 Ani Pharmaceuticals 1.49 Bn 1.13 Bn 165.89 Mn
8 Amphastar Pharmaceuticals 1.00 Bn 714.13 Mn 93.47 Mn
9 Fennec Pharmaceuticals 402.10 Mn 360.85 Mn 17.15 Mn
10 RedHill Biopharma 178.35 Mn 178.35 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 100,000.00
Jun 30, 2023 23.20 Mn
Mar 31, 2023 204.60 Mn
Sep 30, 2022 500.40 Mn
Jun 30, 2022 1.02 Bn
Mar 31, 2022 655.40 Mn
Dec 31, 2021 1.49 Bn
Sep 30, 2021 1.71 Bn
Jun 30, 2021 1.30 Bn
Mar 31, 2021 36.90 Mn
Dec 31, 2020 1.10 Bn